Leukemia Inhibitory Factor Human Recombinant
Leukemia Inhibitory Factor, GST tag Human Recombinant
Leukemia Inhibitory Factor Human Recombinant, His tag
LIF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (a.a 23-202) containing 189 amino acids including a 9 a.a N-terminal His tag. The total molecular mass is 20.9kDa (calculated).
Escherichia Coli.
Leukemia Inhibitory Factor Human Recombinant, Sf9
LIF Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 189 amino acids (23-202a.a.) and having a molecular mass of 20.8kDa (Molecular size on SDS-PAGE will appear at approximately 18-40kDa). LIF is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
LIF Human Recombinant, Yeast
Leukemia Inhibitory Factor Mouse Recombinant
Leukemia Inhibitory Factor Rat Recombinant
Leukemia Inhibitory Factor Receptor Alpha Human Recombinant
Leukemia Inhibitory Factor Receptor Alpha Mouse Recombinant
LIFR Mouse Recombinant produced in Baculovirus is a single glycosylated polypeptide chain containing 794 amino acids (44-828 aa) and having a molecular mass of 89.6kDa.
LIFR is fused to a 9 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques.
Sf9, Baculovirus cells.
Leukemia Inhibitory Factor (LIF) is a cytokine belonging to the interleukin-6 (IL-6) family. It is known for its ability to inhibit the differentiation of myeloid leukemic cells, hence its name . LIF is classified as a polyfunctional glycoprotein cytokine that can affect various cell types and tissues .
LIF exhibits several key biological properties:
LIF has diverse biological functions:
LIF operates through several mechanisms:
The expression and activity of LIF are tightly regulated:
LIF has several applications in biomedical research and therapy:
LIF plays crucial roles throughout the life cycle: